BioMotiv
Finance · Ohio, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
20600 Chagrin Blvd Ste 210, Cleveland, O...Phone Number
(216) 455-3200Website
www.biomotiv.comRevenue
$8.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BioMotiv
BioMotiv is a mission-driven accelerator associated with The Harrington Project for Discovery & Development, a $340 million initiative focused on advancing early stage breakthrough discoveries from research institutions into medicines. Led by a highly accomplished and passionate team of veteran biopharma experts, BioMotiv's innovative model efficiently aligns resources and capital to select, fund, manage and advance a portfolio of drug development programs.Explore more
BioMotiv Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioMotiv your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on BioMotiv recently announced quarterly report
Product Launch: Get notified when BioMotiv launches new products
Check out if BioMotiv is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BioMotiv had a recent Job posting/layoffs
BioMotiv, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once BioMotiv has new funding data
Congratulate Masked Content for being promoted to Masked Content at BioMotiv
Check if BioMotiv has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at BioMotiv
Find 2 more new buyers
Compare Similar Companies to BioMotiv
Compare insights from companies similar to BioMotiv, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioMotiv is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
BioMotiv is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about BioMotiv.
BioMotiv financials insights
Gather financial insights about BioMotiv, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Private Equity
$145.7M
2020
Debt
$150K
BioMotiv Tech Stack
A closer look at the technologies used by BioMotiv
BioMotiv News & Media
BioMotiv, Bristol-Myers Squibb launch Anteros Pharmaceuticals
Anteros Pharmaceuticals will focus on inflammatory diseases.Bristol-Myers, BioMotiv Pact Leads to a New Fibrosis-Focused Startup
Bristol-Myers Squibb is still digesting the commercialized and clinical-stage assets that came with its $74 billion acquisition of Celgene, but the pharmaceutical giant has also been making moves to feed its pipeline with compounds at earlier points of development. An alliance that Bristol struck up with pharmaceutical accelerator BioMotiv last year now has its first […]BioMotiv and Bristol-Myers Squibb Announce the Launch of Anteros Pharmaceuticals
CLEVELAND & NEW YORK--(BUSINESS WIRE)-- #collaboration--BioMotiv and Bristol-Myers Squibb launch of Anteros Pharmaceuticals, focused on developing drugs for fibrotic and other inflammatory diseasesBioMotiv and Bristol-Myers Squibb Launch Anteros Pharma
“Anteros Pharmaceuticals is the first of several companies that BioMotiv and Bristol-Myers Squibb intend to form under the Strategic Partnership Agreement,” said Satish Jindal, BioMotiv’s chief executive officer.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioMotiv
Sign Up For FreeTo access detailed company insights
BioMotiv is a mission-driven accelerator associated with The Harrington Project for Discovery & Development, a $340 million initiative focused on advancing early stage breakthrough discoveries from research institutions into medicines. Led by a highly accomplished and passionate team of veteran biopharma experts, BioMotiv's innovative model efficie... Read More
